Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

58.52
Delayed Data
As of Jul 30
 -0.02 / -0.03%
Today’s Change
52.49
Today|||52-Week Range
63.62
+3.05%
Year-to-Date

Today’s Trading

Previous close58.54
Today’s open58.62
Day’s range58.28 - 58.82
Volume6,989,455
Average volume (3 months)9,431,599
Market cap$165.4B
Dividend yield3.08%
Data as of 4:03pm ET, 07/30/2015

Growth & Valuation

Earnings growth (last year)+176.87%
Earnings growth (this year)-0.15%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-4.48%
P/E ratio15.2
Price/Sales3.95
Price/Book3.42

Competitors

 Today’s
change
Today’s
% change
SNYSanofi+0.93+1.77%
AGNAllergan-9.12-2.70%
NVONovo Nordisk-1.07-1.80%
ABBVAbbVie-0.61-0.86%
Data as of 4:04pm ET, 07/30/2015

Financials

Next reporting dateOctober 26, 2015
EPS forecast (this quarter)$0.91
Annual revenue (last year)$42.1B
Annual profit (last year)$11.9B
Net profit margin28.31%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
Chief Financial Officer &
Executive Vice President
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts